A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Columbia University researchers have created a new topology-based tool that generates a roadmap of the ways in which a stem cell becomes differentiated.
Gordana Vunjak-Novakovic, the Mikati Foundation Professor of Biomedical Engineering, has been appointed a University Professor, Columbia University’s highest academic honor.
The new director of Columbia's Stem Cell Initiative talks about stem cells and aging, the hope for stem cell therapies, and her plans for stem cell research at Columbia.
Studies answer an old debate in developmental biology: How do cells destined to form a particular tissue or structure remember what they're supposed to be?
After hearing many complaints about noisy subway trains, Columbia doctor Anil Lalwani set out to measure the sound profile of stations around the city.
Solving a 60-year-old medical mystery, a team led by Columbia researchers has discovered what causes kidney and urinary tract defects in people with DiGeorge syndrome.